← Back

SUNation Energy Inc.

SUNation Energy Inc. designs, installs, and maintains photovoltaic solar energy systems and battery storage systems in the United States. Its brand portfolio includes SUNation, SUNation Energy, Hawaii Energy Connection, E-Gear, Sungevity, and Horizon Solar Power. The company also develops energy control devices for solar systems paired with batteries, and provides energy and grid services. It serves residential homeowners, commercial owners, municipal customers, energy services companies, and utilities. SUNation Energy Inc. was founded in 1969 and is based in Ronkonkoma, New York.

Price · split & dividend adjusted
News & notes moving SUNE
United States
Energy Transition & Power Demand▼

SUNation Stock Dips After Q2 Earnings, Revenues Decline 37.5%

SUNation Energy shares fell 0.8% after the company reported second-quarter 2026 revenues of $8.2 million, down 37.5% from $13.1 million a year earlier. Net loss narrowed to $3.3 million from $9.6 million, while basic and diluted net loss per share improved to 52 cents from $3.14. Gross profit fell 55.9% to $2.1 million, and consolidated gross margin contracted to 26.1% from 37%. The company also announced a proposed reverse merger with Suniva, Inc., with closing targeted for the fourth quarter of 2026, and completed a $2.7 million private placement at $1.13 per share on June 7.
About megatrends
Energy Transition & Power Demand › Solar ▼Demand
SUNE · Capital · Negative Q2 revenues fell 37.5% and gross margin contracted, though net loss narrowed.
Suniva, Inc. · Capital · Neutral Proposed reverse merger with SUNation announced, but terms and impact unclear.
Read original ↗
Zacks Investment Research·48dRead more →
Energy Transition & Power Demand▼

Zacks Highlights Two Solar Microcaps for Watchlists Amid Operational Shifts

Zacks Investment Research has added two solar microcaps, SUNation Energy and SolarMax Technology, to its watchlist as both companies pursue significant operational transformations. SUNation Energy, which operates in New York and Hawaii, saw first-quarter revenue fall 43.1% year-over-year to $7.2 million and gross margin decline from 35% to 22%, partly due to the expiration of the Section 25D residential solar tax credit at the end of 2025. The company recently announced a merger with solar cell manufacturer Suniva at $2.26 per share, a move that would take it upstream from installation and services into manufacturing. SolarMax Technology reported first-quarter revenue growth of 114% to $14.8 million and a slight positive operating income, as it shifts focus toward large-scale engineering, procurement, and construction contracts for utilities to diversify away from the volatile residential market. Zacks remains on the sidelines for both stocks, citing near-term volatility and, in SolarMax’s case, a history of negative operating cash flow and a sizeable debt load, but notes that operational momentum and execution will be key factors to watch.
About megatrends
Energy Transition & Power Demand › Solar Competition
SMXT · Demand · Neutral Revenue growth 114% and shift to utility-scale EPC contracts, but Zacks on sidelines due to negative cash flow and debt.
SUNE · Demand · Negative First-quarter revenue fell 43.1% and gross margin declined, partly due to expiration of solar tax credit.
Suniva, Inc. · Capital · Neutral Mentioned as merger partner for SUNation, but no standalone financials or operational details provided.
Read original ↗
Zacks Investment Research·79dRead more →
SUNE

Halper Sadeh LLC Investigates IRDM, TECH, SUNE, ACA Deals for Shareholder Fairness

Halper Sadeh LLC, an investor rights law firm, is investigating Iridium Communications, Bio-Techne, SUNation Energy, and Arcosa for potential securities law violations or fiduciary duty breaches related to their proposed transactions. The firm is examining Iridium's sale to Rocket Lab for $27.00 in cash plus Rocket Lab shares, Bio-Techne's sale to Merck KGaA for $73.00 per share in cash, SUNation Energy's merger with Suniva where SUNation shareholders would own about 1.8% of the combined company, and Arcosa's sale to CRH for $150.00 per share. Halper Sadeh may seek increased consideration, additional disclosures, or other relief on behalf of shareholders, and encourages affected investors to contact the firm at no cost to discuss their legal rights and options.
ACA · Capital · Neutral Arcosa's sale to CRH is being investigated for potential shareholder unfairness, which could lead to improved terms or additional disclosures.
IRDM · Capital · Neutral Iridium's sale to Rocket Lab is under investigation for potential securities law violations or fiduciary duty breaches.
SUNE · Capital · Neutral SUNation Energy's merger with Suniva is being investigated for potential unfairness to shareholders.
TECH · Capital · Neutral Bio-Techne's sale to Merck KGaA is under investigation for potential securities law violations or fiduciary duty breaches.
Read original ↗
GlobeNewswire·96dRead more →
SUNE

Halper Sadeh LLC Investigates Fairness of Deals for LPRO, NUVL, OGN, SUNE Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the proposed sales of Open Lending Corporation, Nuvalent Inc., Organon & Co., and SUNation Energy Inc. are fair to shareholders. The firm is examining Open Lending's sale to ANV Group Holdings Ltd. for $3.15 per share, Nuvalent's sale to GSK plc for $124.00 per share in cash, Organon's sale to Sun Pharmaceutical Industries Limited for $14.00 per share, and SUNation Energy's merger with Suniva, in which SUNation shareholders would own approximately 1.8% of the combined company. Halper Sadeh LLC may seek increased consideration, additional disclosures, or other relief on behalf of shareholders, and encourages investors to contact the firm to discuss their rights at no cost.
LPRO · Capital · Neutral Investigation into fairness of Open Lending's sale to ANV Group Holdings for $3.15 per share; may seek increased consideration or additional disclosures.
NUVL · Capital · Neutral Investigation into fairness of Nuvalent's sale to GSK for $124.00 per share; may seek increased consideration or additional disclosures.
OGN · Capital · Neutral Investigation into fairness of Organon's sale to Sun Pharmaceutical for $14.00 per share; may seek increased consideration or additional disclosures.
SUNE · Capital · Neutral Investigation into fairness of SUNation Energy's merger with Suniva, where SUNation shareholders would own ~1.8% of combined company; may seek increased consideration or additional disclosures.
Read original ↗
GlobeNewswire·110dRead more →